Evidence map›Paper›PMID 37742282›Full record

ArticleArchives of microbiology2023

Characterization and description of Gabonibacter chumensis sp. nov., isolated from feces of a patient with non-small cell lung cancer treated with immunotherapy.

Khoudia Diop, Reilly Pidgeon, Awa Diop, Myriam Benlaïfaoui, Wiam Belkaid, Julie Malo, Eve Bernet, Frederic Veyrier, Maxime Jacq, Yves Brun and 4 more

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Archives of microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 2 countries.

Khoudia DiopLaboratory of Immunotherapy and Onco-Microbiome, University of Montreal Healthcare Research Center (CRCHUM), 900 Rue Saint-Denis, Montreal, QC, H2X 0A9, Canada. khoudia.diop@umontreal.ca.
Reilly PidgeonDepartment of Pharmacology & Therapeutics, Faculty of Medicine and Health Sciences, McGill University, 3655 Promenade Sir-William-Osler, Montreal, QC, H3G 1Y6, Canada.
Awa DiopDepartment of Biology, University of North Carolina Greensboro, 321 McIver Street, PO Box 26170, Greensboro, NC, 27402, USA.
Myriam BenlaïfaouiLaboratory of Immunotherapy and Onco-Microbiome, University of Montreal Healthcare Research Center (CRCHUM), 900 Rue Saint-Denis, Montreal, QC, H2X 0A9, Canada.
Wiam BelkaidLaboratory of Immunotherapy and Onco-Microbiome, University of Montreal Healthcare Research Center (CRCHUM), 900 Rue Saint-Denis, Montreal, QC, H2X 0A9, Canada.
Julie MaloLaboratory of Immunotherapy and Onco-Microbiome, University of Montreal Healthcare Research Center (CRCHUM), 900 Rue Saint-Denis, Montreal, QC, H2X 0A9, Canada.
Eve BernetINRS-Centre Armand-Frappier Santé Biotechnologie, Bacterial Symbionts Evolution, Laval, QC, H7V 1B7, Canada.
Frederic VeyrierINRS-Centre Armand-Frappier Santé Biotechnologie, Bacterial Symbionts Evolution, Laval, QC, H7V 1B7, Canada.
Maxime JacqFaculty of Medicine, Department of Microbiology and Immunology, University of Montreal, Montreal, QC, Canada.
Yves BrunFaculty of Medicine, Department of Microbiology and Immunology, University of Montreal, Montreal, QC, Canada.
Arielle ElkriefLaboratory of Immunotherapy and Onco-Microbiome, University of Montreal Healthcare Research Center (CRCHUM), 900 Rue Saint-Denis, Montreal, QC, H2X 0A9, Canada.
Bastien CastagnerDepartment of Pharmacology & Therapeutics, Faculty of Medicine and Health Sciences, McGill University, 3655 Promenade Sir-William-Osler, Montreal, QC, H3G 1Y6, Canada.
Bertrand RoutyLaboratory of Immunotherapy and Onco-Microbiome, University of Montreal Healthcare Research Center (CRCHUM), 900 Rue Saint-Denis, Montreal, QC, H2X 0A9, Canada. bertrand.routy@umontreal.ca.
Corentin RichardLaboratory of Immunotherapy and Onco-Microbiome, University of Montreal Healthcare Research Center (CRCHUM), 900 Rue Saint-Denis, Montreal, QC, H2X 0A9, Canada.
Université de Montréal · CAInstitut National de la Recherche Scientifique · CAMcGill University · CAMcGill University Health Centre · CAUniversity of North Carolina at Greensboro · US

Funding

CIHR 420356CIHR 437944CIHR Canada 150 Research Chair in Bacterial Cell Biology
6 · The paper itself

Abstract

A polyphasic taxonomic approach, incorporating analysis of phenotypic features, cellular fatty acid profiles, 16S rRNA gene sequences, and determination of average nucleotide identity (ANI) plus digital DNA-DNA hybridization (dDDH), was applied to characterize an anaerobic bacterial strain designated KD22

Indexed as

Carcinoma, Non-Small-Cell LungLung NeoplasmsFatty AcidsFecesHumansImmunotherapyPhylogenyRNA, Ribosomal, 16SFatty AcidsRNA, Ribosomal, 16SBacteriaCancerGabonibacter chumensisGut microbiotaImmunotherapyNon-small cell lung cancer

Identifiers

PMID37742282
PMCPMC10518271
OpenAlexW4386998232

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.